Novo CEO pressed by Senate to chop rates of obesity, diabetic issues medicines CEO Lars Fruergaard Jørgensen told lawmakers the company would think about new talks with insurers with regards to the list selling prices of Wegovy and copyright if they pledge to maintain the medicines on their own formularies. https://kethek.com/